Katahdin Bankshares Declares 023 Quarterly Dividend AutoNation TJX and Alibaba in Focus as Markets Digest Mixed Sector Signals March Core Inflation Hits 32 as Q1 GDP Growth Slows to 2 Geopolitical Tensions Add Pressure on Federal Reserve Consumer Price Index Surges to 38 in April Marking Highest Annual Inflation Since May 2023 Besset Predicts Substantial Disinflation as Fed Leadership Transitions to Warsh Zacks SmallCop Research Boosts FatPipe Valuation to 640 Following Preliminary Q4 Update OVLY Q3 2023 Earnings EPS of 089 Reflects Steady Performance Amid Challenging Rate Environment RMBI Q1 2026 Earnings Solid EPS Amidst Flat Market Reaction TRIP Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty NAT Q4 2025 Earnings EPS Falls 56 Short of Estimates as Tanker Market Weakens Alexanders Inc ALX Q1 2026 Earnings Solid EPS Performance Amid Market Uncertainty General Mills Q1 2026 Earnings EPS Misses Estimates by Nearly 13 as Stock Edges Higher Dingdong DDL Slips 091 as Stock Hovers Near Key Support Level Synthetic FixedIncome Securities Inc STRATS Trust for PG Securities GJR Holds Steady at 2475 Amid Low Volatility Eaton Vance Global Dividend Income Fund ETG Edges Higher Approaching Resistance at 2413 Flaherty Crumrine Dynamic Preferred and Income Fund DFP Edges Higher in Measured Trading Intercorp Financial Services IFS Slips 105 as Shares Navigate Between Key Support and Resistance Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Estate Planning Strategies for HighIncome Trusts Shifting Tax Burden to Beneficiaries JP Power Vodafone Idea Easy Trip Planners Lead NSEs Most Traded Stocks on 27 May 2026 Spotify CEO Defends AI Music Integration Calls Remix Tool a Better Alternative to Unlicensed Slop Geopolitical Tensions Escalate After Russia Accuses Ukraine of Strike on Dormitory Kyiv Targets Drone Unit Principal Financial Group Faces Analyst Uncertainty Amid Retirement Market Shifts GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain Cue Biopharma CUE Shows Modest Gain as Biotech Sector Watches Key Levels